Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,121,559
+$161,341 QoQ
Shares Held
4,457
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#2,438
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tempus Wealth Planning, LLC holds $12,281,697 across 10 Drug Manufacturers - General names. ABBV ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,351 | $2,819,860 | |
| 2 | AMGN |
Amgen Inc
|
6,252 | $2,263,974 | |
| 3 | JNJ |
Johnson & Johnson
|
8,489 | $2,155,951 | |
| 4 | PFE |
Pfizer Inc
|
48,325 | $1,163,666 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
4,457 | $1,121,559 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,491 | $962,593 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
15,761 | $908,148 | |
| 8 | NVO |
Novo Nordisk A S
|
7,909 | $379,157 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,121,559 | 4,457 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $960,218 | 4,415 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,005,356 | 4,400 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,194,977 | 5,161 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $842,157 | 4,537 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $604,884 | 2,887 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $548,382 | 3,086 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $595,994 | 3,018 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $491,747 | 2,867 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $467,632 | 2,568 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $359,065 | 2,317 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $345,372 | 2,317 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $626,494 | 4,650 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $768,960 | 4,825 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $743,244 | 4,599 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $570,392 | 4,250 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $595,332 | 3,887 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $628,176 | 3,875 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $578,564 | 4,273 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $461,899 | 4,282 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $442,112 | 3,925 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $408,638 | 3,776 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $402,991 | 3,761 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $343,352 | 3,920 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $383,392 | 3,905 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $283,198 | 3,717 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||